Compare Procrit vs. Neupogen

Head-to-head comparisons of medication uses, side effects, ratings, and more.

Procrit (epoetin alfa)

Prescription only

Neupogen (filgrastim)

Prescription only
Treats low red blood cell count.

Procrit (epoetin alfa) is effective at treating low red blood cell count, but it might cause tumor growth and increased risk of blood clots.

Prevents infection during chemotherapy.

Neupogen (filgrastim) can lower your risk of infection during chemotherapy, but it can cause a significant amount of bone pain.

Upsides
  • Procrit (epoetin alfa) is effective at treating anemia if you have kidney problems or cancer.
  • Procrit (epoetin alfa) doesn't have to be injected every day.
  • There are no dosage adjustments if you have kidney and liver problems.
  • Neupogen (filgrastim) is effective at preventing infection during chemotherapy.
  • There are no dosage adjustments if you have kidney and liver problems.
Downsides
  • Procrit (epoetin alfa) is only available as an injectable.
  • When using Procrit (epoetin alfa), your blood has to be constantly monitored.
  • Procrit (epoetin alfa) is not available as a generic and is expensive.
  • You must have normal iron levels before starting Procrit (epoetin alfa).
  • If you have high blood pressure, Procrit (epoetin alfa) may not be the right medication for you.
  • If you decide not to self-inject and don't have someone to do it for you, you'll need to have your doctor or trained medical staff give you each dose of Neupogen (filgrastim).
  • You'll need to properly dispose of the needle and syringe in a special (FDA-approved) sharps container.
  • Neupogen (filgrastim) is not available as a generic, and is expensive.
  • Neupogen (filgrastim) is injected every day, whereas Neulasta is injected every 10-14 days.
Used for
  • Anemia due to chemotherapy in cancer patients
  • Anemia due to chronic kidney disease
  • Anemia due to zidovudine in HIV-infected patients
  • Reduction of Allogeneic Red Blood Cell Transfusions in Patients Undergoing Elective, Noncardiac, Nonvascular Surgery
  • Severe chronic neutropenia
  • Febrile neutropenia prophylaxis in myelosuppressive chemotherapy recipients with nonmyeloid malignancies
  • Febrile neutropenia prophylaxis in acute myeloid leukemia (AML) following induction or consolidation chemotherapy
  • Bone marrow transplantation
  • Hematopoietic radiation injury syndrome
  • Peripheral blood progenitor cell collection and therapy
Dosage forms
  • Injection
  • Injection
Price
Lowest price near you
$2007.82
Find instant savings
Lowest price near you
$340.11
Find instant savings
Want to save even more money?
Sign up now for a 30-day trial and save up to 95% at Kroger, Albertsons, Safeway, and other pharmacies.
Reviews
Not enough review data.Leave a review
Not enough review data.Leave a review
Side effects
7possible side effects
  • Fever
    42%
  • Nausea
    35%
  • High blood pressure
    28%
  • Cough
    26%
  • Vomiting
    20%
  • Rash
    19%
  • Joint pain
    16%
See more detailed side effects
10possible side effects
  • Fever
    48%
  • Nausea
    43%
  • Decreased platelets
    38%
  • Fatigue
    20%
  • Back pain
    15%
  • Dizziness
    14%
  • Cough
    14%
  • Rash
    14%
  • Chest pain
    13%
  • Shortness of breath
    13%
See more detailed side effects
Risks and warnings
  • Increased risk of death and other serious events

    History of heart disease

    ...and 2 more risk factors

  • Seizures

    History of seizures.

See more detailed risks and warnings
  • Serious allergic reactions

    Allergy to Neupogen (filgrastim)

  • Blood problems

    Sickle cell disease

    ...and 1 more risk factors

  • Malignancy

    History of myeloid cancers or myelodysplastic conditions

See more detailed risks and warnings